Earnest Partners LLC Teva Pharmaceutical Industries LTD Transaction History

Earnest Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $1,605 - $2,731	143 New	143 $3,000
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $46.1 Million - $96.3 Million	-2,992,743 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,992,743	2,992,743 $99.4 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Earnest Partners LLC with notifications on news.